pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
637
stories
10h
Significant stock movers of September: Viking soars, Longeveron slides
biospace
14h
Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset
biospace
15h
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
biopharma dive
15h
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
stat
15h
CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential
biospace
18h
Genentech pays Alector $100M for preclinical Parkinson’s prospect
fiercebiotech
20h
Opinion: Energy drinks’ new college sports partnerships make them more dangerous than ever
stat
1d
CSL pays $355M to co-develop Alentis’ phase 2-stage fibrosis drug
fiercebiotech
1d
Infusion Set Recall: BD and CareFusion 303, Inc. Remove BD Alaris Pump Infusion Sets
fda medwatch
1d
IV Tubing Set Correction: ICU Medical Updates Use Instructions for IV Tubing Sets
fda medwatch
1d
FDA signs off on first heart valve designed to dynamically expand in children
fiercebiotech
3d
BMO most bullish on Merck's, bearish on BMS’ plans to contend with patent cliffs
biospace
3d
Foghorn cuts 40% of workforce
biospace
3d
Novartis wagers almost $8B on a Chinese biotech’s RNA drugs
biopharma dive
4d
Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager
fiercebiotech
4d
Abbott launches SimpleScreen CRC blood test in the US
fiercebiotech
4d
Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
fda recalls
4d
STAT+: Medicare Advantage plans shift more costs onto seniors in 2027
stat
4d
FDA Approves First Heart Valve Designed to Grow with Children
fda press
4d
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
4d
Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
biospace
4d
Opinion: Claude analyzed my genome in 30 minutes. Now we need standards for the results
stat
4d
Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3
fiercebiotech
5d
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
biopharma dive
5d
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
biospace
5d
STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
stat
5d
Lilly builds commercial case for GLP-1 products over Novo with indirect analyses
biospace
5d
Lilly raises diabetes weight-loss bar with amylin-Zepbound combo
fiercebiotech
6d
Lilly sets up next-gen obesity battle with full phase 3 retatrutide data
fiercebiotech
6d
STAT+: PhRMA taps Eric Cantor as new CEO
stat
← prev
page 1 of 22
next →
